Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alyssa P. Gould"'
Autor:
Majdi N. Al-Hasan, Alyssa P. Gould, Chelsea Drennan, Olivia Hill, Julie Ann Justo, Joseph Kohn, P. Brandon Bookstaver
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 22, Iss , Pp 87-93 (2020)
Objectives: Increasing antimicrobial resistance rates limit empirical antimicrobial treatment options for Gram-negative bloodstream infections (GN-BSI). However, antimicrobial resistance may be predicted based on patient-specific risk factors using p
Externí odkaz:
https://doaj.org/article/0e968f46680642218eddb12d81abc7c9
Autor:
Jacinta Chin, Sarah B. Green, Lacie J. McKamey, Michael D. Gooch, Ryan W. Chapin, Alyssa P. Gould, Stephanie F. Milliken, Lisa M. Blanchette
Publikováno v:
Infection Prevention in Practice, Vol 1, Iss 2, Pp - (2019)
Summary: Background: Fluoroquinolone (FQ) antibiotics have become a target of many antimicrobial stewardship programmes. Multiple post-marketing warnings from the Food and Drug Administration caution against use of this drug class for certain infecti
Externí odkaz:
https://doaj.org/article/dc3e07e3692a4173ad4737e0394f0356
Autor:
Alyssa P Gould, Robert L Crawford
Publikováno v:
Open Forum Infectious Diseases. 9
Background The optimal duration of antimicrobial therapy for non-staphylococcal Gram-positive (GP) bloodstream infections (BSIs) remains unknown. The purpose of this study was to evaluate clinical outcomes in patients with short (6-10 days) vs. long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5046c5fb807dc3e971b6b726d06f0a11
https://doi.org/10.1093/ofid/ofac492.1445
https://doi.org/10.1093/ofid/ofac492.1445
Autor:
Julie Ann Justo, Mary Sheffield, P. Brandon Bookstaver, Jennifer Hucks, Dana Nelson, Alyssa P. Gould, Jeannette Bouchard, Melissa O’Neal, David P. Nicolau
Publikováno v:
International journal of antimicrobial agents. 56(5)
Ceftolozane/tazobactam (C/T), a novel antipseudomonal cephalosporin plus β-lactamase inhibitor, is used in multidrug-resistant Gram-negative infections. Continuous infusion (CI) of C/T is an attractive concept for aiding in transitions of care and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee6440a9b9fc666d2a41d74307cb205
https://pubmed.ncbi.nlm.nih.gov/32919007
https://pubmed.ncbi.nlm.nih.gov/32919007
Autor:
Lea S. Eiland, Milena M. McLaughlin, Brooke Griffin, Christopher M. Bland, Alyssa P. Gould, Kayla R. Stover, Hana Rac, P. Brandon Bookstaver
Publikováno v:
Annals of Pharmacotherapy. 53:639-651
Objective: To review the treatment of common bacterial and viral infections occurring in the pregnant patient. Data Sources: A literature search of MEDLINE was performed (inception to October 2018). The Centers for Disease Control and Prevention webs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce46224bc7fe1d5d27c0200209dd43e
https://doi.org/10.1177/1060028018817935
https://doi.org/10.1177/1060028018817935
Autor:
Olivia Hill, P. Brandon Bookstaver, Alyssa P. Gould, Julie Ann Justo, Joseph Kohn, Chelsea Drennan, Majdi N. Al-Hasan
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 22, Iss, Pp 87-93 (2020)
Objectives Increasing antimicrobial resistance rates limit empirical antimicrobial treatment options for Gram-negative bloodstream infections (GN-BSI). However, antimicrobial resistance may be predicted based on patient-specific risk factors using pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7aca73592f7f78e26c049139d042081
https://pubmed.ncbi.nlm.nih.gov/31887412
https://pubmed.ncbi.nlm.nih.gov/31887412
Autor:
Sarah Elizabeth B Davis, Julie Ann Justo, P. Brandon Bookstaver, Jennifer Hucks, David P. Nicolau, Jared Ham, Rachel A Foster, Alyssa P. Gould
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(8)
PurposeThe safe and effective use of ceftolozane–tazobactam delivered via continuous infusion in a cystic fibrosis (CF) patient with reduced body weight and presumed augmented renal clearance is reported.SummaryA 30-year-old woman with CF was admit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f88091bfbe37e58b5ea45c95ecc4d44
https://pubmed.ncbi.nlm.nih.gov/31361864
https://pubmed.ncbi.nlm.nih.gov/31361864
Autor:
P. Brandon Bookstaver, Majdi N. Al-Hasan, Joseph Kohn, Alyssa P. Gould, Julie Ann Justo, Hana Rac
Publikováno v:
Open Forum Infectious Diseases
Background Early identification of patients at high risk of morbidity and mortality following Gram-negative bloodstream infections (GN-BSI) based on initial clinical course may prompt adjustments to optimize diagnostic and treatment plans. This retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e73492c60869db3d2d7d458cd69edc9d
http://europepmc.org/articles/PMC6255120
http://europepmc.org/articles/PMC6255120
Autor:
Julie Ann Justo, Rachel A. Foster, Stella Okoye, Alyssa P Gould, P. Brandon Bookstaver, David P. Nicolau
Publikováno v:
Open Forum Infectious Diseases
Background Pseudomonas aeruginosa is a common pathogen in left ventricular assist device (LVAD) infections. Ceftolozane/tazobactam (C/T) is a β-lactam/β-lactamase inhibitor with activity against P. Aeruginosa, including multi-drug-resistant (MDR) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::478f4866550b741620889719161c9b5b
https://doi.org/10.1093/ofid/ofx163.635
https://doi.org/10.1093/ofid/ofx163.635
Autor:
Alyssa P Gould, Hana R Winders, Kayla R Stover, P Brandon Bookstaver, Brooke Griffin, Christopher M Bland, Lea S Eiland, Milena Murray
Publikováno v:
Drugs in Context, Vol 10, Pp 1-17 (2021)
This review is a comprehensive summary of treatment options for pregnant patients with less common bacterial, fungal, and viral infections. It offers guidance to clinicians based on the most recently published evidence-based research and expert recom
Externí odkaz:
https://doaj.org/article/7ad46bcdb1ad47d1aaf054b8ce559ac0